This gp130Y757F mutation impairs SOCS3-mediated negative feedback regulation, leading to hyperactivation of the IL-6/JAK/STAT3 pathway, which is one of the most frequently dysregulated signaling cascades in human gastric cancer and is associated with inflammation, proliferation, and immune evasion. This evidence concerns the gene IL6 and gastric cancer.